OSTX

OS Therapies Inc

Healthcare · Biotechnology

$227.46 sample

+0.30 (+0.13%) 1D

Market cap

$733.3B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-18

Alerts

8

Price$227.46 -3.08% 3M daily closessample

235.70218.91

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider sell: Chief Financial Officer
Oct 08INSInsider sell: 10% owner
Sep 30INSInsider sell: EVP, Operations
Sep 25INSInsider sell: Chief Executive Officer
Sep 18SECDEF 14A filed
Sep 15SECForm 144 filed
Sep 09INSInsider buy: Chief Financial Officer
Sep 03SECDEF 14A filed

Sign up to see the real OSTX record →

Company facts

SEC EDGAR registration

Name: OS Therapies Inc
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +7sample, -100 to +100
Reporting currency: USD

Who is positioning in OSTX

sample

Insiders: 10 insider transactions over 90 days, net selling, $506.8M
Congress: 5 members traded over 90 days
Institutions · 13F: 16 funds hold $16.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$36.9B +14.3% y/y

Q4 2024Q3 2026

Inventory$23.0B +11.8% y/y

Q4 2024Q3 2026

Accounts receivable$17.5B +21.3% y/y

Q4 2024Q3 2026

Total debt$44.4B +13.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $339.4B -4.1% 3M
Sample peer B: $163.8B +2.2% 3M
Sample peer C: $421.1B -9.6% 3M
Sample peer D: $329.5B +0.7% 3M
Sample peer E: $663.9B -4.7% 3M